Results 131 to 140 of about 59,070 (244)

Mid‐ to long‐term outcomes of capsular management in hip arthroscopy for FAIS: A multilevel meta‐analysis

Knee Surgery, Sports Traumatology, Arthroscopy, Volume 34, Issue 2, Page 666-683, February 2026.
Abstract Purpose To compare mid‐ to long‐term outcomes of the three major capsular management strategies—capsule preserved (CP), capsule repaired (CR) and capsule unrepaired (CU)—following hip arthroscopy (HAS) for femoroacetabular impingement syndrome (FAIS).
Nikolai Ramadanov, Maximilian Voss, Robert Hable, Robert Prill, Roland Becker, Ingo J. Banke   +5 more
wiley   +1 more source

First Total Robotic Living Donor Liver Transplantation in North America

The International Journal of Medical Robotics and Computer Assisted Surgery, Volume 22, Issue 1, February 2026.
ABSTRACT Background The application of robotic technology to liver transplantation is challenging due to the procedure's complexity. Methods We present the first robotic living donor liver transplantation performed in North America, detailing our stepwise implementation and key technical aspects.
Yuzuru Sambommatsu, Kush Savsani, Vinay Kumaran, Andrew Park, Shilpa Jasti, Eric Qian, Daisuke Imai, Aamir A. Khan, Amit Sharma, Muhammad Saeed, Adrian H. Cotterell, Seung Duk Lee, David A. Bruno   +12 more
wiley   +1 more source

Normothermic Regional Perfusion in Controlled Donation After Circulatory Death: Growing Evidence for Liver Transplantation

Clinical Transplantation, Volume 40, Issue 2, February 2026.
ABSTRACT Normothermic regional perfusion (NRP) has emerged as a pivotal strategy in controlled donation after circulatory death (cDCD) liver transplantation, mitigating ischemia‐reperfusion injury and improving graft outcomes. Compared to super rapid recovery (SRR), NRP significantly reduces rates of early allograft dysfunction, primary nonfunction ...
Daisuke Imai, Jacob Hallesy, Rohan Rathi, Christian Zbihley, Kush Savsani, Yuzuru Sambommatsu, Aamir A. Khan, Vinay Kumaran, David A. Bruno, Seung Duk Lee   +9 more
wiley   +1 more source

Real‐World Effectiveness and Safety of Damoctocog Alfa Pegol in Severe and Nonsevere Patients With Hemophilia A From the Prospective, Multinational, Ongoing HEM‐POWR Study

European Journal of Haematology, Volume 116, Issue 2, Page 148-159, February 2026.
ABSTRACT Objectives To assess the effectiveness and safety of damoctocog alfa pegol in patients with severe and nonsevere hemophilia A in the fifth interim analysis of the ongoing HEM‐POWR study. Methods HEM‐POWR (NCT03932201) is a multinational, Phase 4, prospective observational study.
Mark T. Reding, María Teresa Alvarez Román, Giancarlo Castaman, Maissaa Janbain, Tadashi Matsushita, Karina Meijer, Kathrin Schmidt, Johannes Oldenburg   +7 more
wiley   +1 more source

Portal Vein Thrombosis

Samant H, Asafo-Agyei KO, Kimyaghalam A, Garfield K.   +3 more
europepmc   +3 more sources

Efficacy and Safety of Hypofractionated Radiation Therapy Combined With Immunotherapy for Hepatocellular Carcinoma With Vp4 Portal Vein Tumor Thrombosis

Hepatology Research, Volume 56, Issue 2, Page 246-252, February 2026.
ABSTRACT Background Hepatocellular carcinoma (HCC) with Vp4 portal vein tumor thrombosis (PVTT) has an extremely poor prognosis, and evidence for effective systemic therapy is limited. Preclinical studies suggest that hypofractionated radiation therapy (HFRT) may enhance immune checkpoint inhibitor (ICI) efficacy through immunogenic cell death and ...
Masahiko Tameda, Hideaki Tanaka, Yutaka Toyomasu, Mizuki Kawachi, Hirono Owa, Mone Tsukimoto, Yasuyuki Tamai, Naoto Fujiwara, Ryuta Shigefuku, Suguru Ogura, Yoshihito Nomoto, Hayato Nakagawa   +11 more
wiley   +1 more source

Pancreatic transplantation at the University of Pittsburgh. [PDF]

, 2004
Campath-1H preconditioning with tacrolimus monotherapy is an effective immunosuppressive regimen for pancreas transplantation, with acceptable patient and graft survival rates early after transplantation.
Abu-Elmagd, K, Basu, A, Bond, G, Khan, A, Marcos, A, Mazariegos, G, Reyes, J, Shapiro, R, Sindhi, R, Starzl, TE, Tan, HP, Thai, NL, Tom, K   +12 more
core  

Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study

Liver International, Volume 46, Issue 2, February 2026.
ABSTRACT Background/Aims Immune checkpoint inhibitors (ICIs) have transformed advanced HCC treatment. The benefit of sequential immunotherapy after prior ICI failure remains unclear. Given the expanded use of atezolizumab plus bevacizumab (Ate/Bev) over the past 5 years, we explored the real‐world outcomes of nivolumab plus ipilimumab (Nivo/Ipi) in ...
Jung Sun Kim, Jeffrey Wong, San‐Chi Chen, David Tai, Hannah Yang, Youngun Kim, Beodeul Kang, Ilhwan Kim, Hyeyeong Kim, Chansik An, Su Jin Jang, Masatoshi Kudo, Ho Yeong Lim, Chan Kim, Thomas Yau, Hong Jae Chon   +15 more
wiley   +1 more source

GDF‐15 Levels in Cirrhosis Are Linked to Hepatic Fibrogenesis, Bacterial Translocation, and Worse Clinical Outcomes

Liver International, Volume 46, Issue 2, February 2026.
ABSTRACT Background &Aims Growth differentiation factor‐15 (GDF‐15), a cell stress‐induced cytokine, is implicated in liver disease pathophysiology. We investigated GDF‐15 in cirrhosis, focusing on its association with disease‐driving pathomechanisms, platelet function, hepatic decompensation, and mortality.
Benedikt Silvester Hofer, Thomas Perkmann, Ksenia Brusilovskaya, Lorenz Balcar, Marlene Hintersteininger, Georg Kramer, Benedikt Simbrunner, Esther Caparros, Rubén Francés, Beate Eichelberger, Silvia Lee, Kerstin Zinober, Benjamin Bödendorfer, Borka Radovanovic‐Petrova, Paul Thöne, Christian Sebesta, Mathias Jachs, Lukas Hartl, Philipp Schwabl, Mattias Mandorfer, Simon Panzer, Thomas Reiberger, Thomas Gremmel   +22 more
wiley   +1 more source

Portal vein thrombosis in a patient on semaglutide. [PDF]

Qatar Med J
Farooqi MF, Khan M, Arshad M, Agha A.
europepmc   +2 more sources